These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31406044)

  • 1. [The role of iron overload in the progression of nonalcoholic steatohepatitis (NASH)].
    Atarashi M; Izawa T; Kuwamura M; Yamate J
    Nihon Yakurigaku Zasshi; 2019; 154(2):61-65. PubMed ID: 31406044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis.
    Atarashi M; Izawa T; Miyagi R; Ohji S; Hashimoto A; Kuwamura M; Yamate J
    Nutrients; 2018 Feb; 10(2):. PubMed ID: 29401710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron overload in nonalcoholic steatohepatitis.
    Fujita N; Takei Y
    Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective autophagy associated with iron overload aggravates non-alcoholic steatohepatitis via ferroptosis.
    Honma K; Kirihara S; Nakayama H; Fukuoka T; Ohara T; Kitamori K; Sato I; Hirohata S; Fujii M; Yamamoto S; Ran S; Watanabe S
    Exp Biol Med (Maywood); 2023 Jul; 248(13):1112-1123. PubMed ID: 37646078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis.
    Handa P; Thomas S; Morgan-Stevenson V; Maliken BD; Gochanour E; Boukhar S; Yeh MM; Kowdley KV
    J Leukoc Biol; 2019 May; 105(5):1015-1026. PubMed ID: 30835899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
    Wu J
    Oncotarget; 2016 Jul; 7(27):42762-42776. PubMed ID: 27072576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice.
    Handa P; Morgan-Stevenson V; Maliken BD; Nelson JE; Washington S; Westerman M; Yeh MM; Kowdley KV
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G117-27. PubMed ID: 26564716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Kramer JA; Grindley J; Crowell AM; Makaron L; Kohli R; Kirby M; Mansfield KG; Wachtman LM
    Vet Pathol; 2015 Mar; 52(2):404-13. PubMed ID: 24913270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary Iron Overload Abrogates Chemically-Induced Liver Cirrhosis in Rats.
    Atarashi M; Izawa T; Mori M; Inai Y; Kuwamura M; Yamate J
    Nutrients; 2018 Oct; 10(10):. PubMed ID: 30279328
    [TBL] [Abstract][Full Text] [Related]  

  • 11.  Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis.
    Handa P; Vemulakonda AL; Maliken BD; Morgan-Stevenson V; Nelson JE; Dhillon BK; Hennessey KA; Gupta R; Yeh MM; Kowdley KV
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):77-85. PubMed ID: 28051796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease.
    Buzzetti E; Petta S; Manuguerra R; Luong TV; Cabibi D; Corradini E; Craxì A; Pinzani M; Tsochatzis E; Pietrangelo A
    Liver Int; 2019 Jul; 39(7):1325-1334. PubMed ID: 30851216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study.
    Rostoker G; Loridon C; Griuncelli M; Rabaté C; Lepeytre F; Ureña-Torres P; Issad B; Ghali N; Cohen Y
    EBioMedicine; 2019 Jan; 39():461-471. PubMed ID: 30502056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.
    Uraz S; Aygun C; Sonsuz A; Ozbay G
    Dig Dis Sci; 2005 May; 50(5):964-9. PubMed ID: 15906776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis.
    Kurbatova IV; Topchieva LV; Dudanova OP; Shipovskaya AA
    Ter Arkh; 2019 May; 91(4):21-27. PubMed ID: 31094472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Manne V; Handa P; Kowdley KV
    Clin Liver Dis; 2018 Feb; 22(1):23-37. PubMed ID: 29128059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and non-alcoholic fatty liver diseases.
    Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
    World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.
    Wang L; Wu S; Cai M; Ma J; Li S; Li M; Xu Y; Wei L; Shang J
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis.
    Gao H; Jin Z; Bandyopadhyay G; Wang G; Zhang D; Rocha KCE; Liu X; Zhao H; Kisseleva T; Brenner DA; Karin M; Ying W
    Cell Metab; 2022 Aug; 34(8):1201-1213.e5. PubMed ID: 35921818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.